Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Communication
  • Published:

Upregulated c-myc expression in multiple myeloma by internal ribosome entry results from increased interactions with and expression of PTB-1 and YB-1

Abstract

The 5′ untranslated region of the proto-oncogene c-myc contains an internal ribosome entry segment (IRES) and c-myc translation can therefore be initiated by internal ribosome entry as well as by cap-dependent mechanisms. It has been shown previously that in patients with multiple myeloma (MM) and in MM-derived cell lines there is a C to T mutation in the c-myc IRES that increases IRES activity and the corresponding synthesis of c-myc protein although it is not fully understood how this occurs. Our data show that two recently identified c-myc IRES trans-acting factors, Y-box binding protein 1 (YB-1) and polypyrimidine tract-binding protein 1 (PTB-1), bind more strongly (approximately 3.5- and 2-fold respectively) to the mutated version of the c-myc IRES and in vitro these proteins exert their effect synergistically to stimulate IRES activity of the mutant IRES 4.5-fold more than the wild-type version. Importantly, we show that there is a strong correlation between the expression of PTB-1, YB-1 and c-myc in MM-derived cell lines, suggesting that by reducing either PTB-1 or YB-1 protein levels it is possible to decrease c-myc expression and inhibit cell proliferation of MM-derived cell lines.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Bader AG, Vogt PK . (2008). Phosphorylation by Akt disables the anti-oncogenic activity of YB-1. Oncogene 27: 1179–1182.

    Article  CAS  PubMed  Google Scholar 

  • Blackwood EM, Eisenman RN . (1991). Max; a helix–loop–helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 251: 1211–1217.

    Article  CAS  PubMed  Google Scholar 

  • Boutz PL, Stoilov P, Li Q, Lin CH, Chawla G, Ostrow K et al. (2007). A post-transcriptional regulatory switch in polypyrimidine tract-binding proteins reprograms alternative splicing in developing neurons. Genes Dev 21: 1636–1652.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chappell SA, Le Quesne JPC, Paulin FEM, deSchoolmeester ML, Stoneley M, Soutar RL et al. (2000). A mutation in the c-myc IRES leads to enhanced internal ribosome entry in multiple myelome: a novel mechanism of oncogene de-regulation. Oncogene 19: 4437–4440.

    Article  CAS  PubMed  Google Scholar 

  • Chatterjee M, Rancso C, Stuhmer T, Eckstein N, Andrulis M, Gerecke C et al. (2008). The Y-box protein YB-1 is associated with progressive disease and mediates survival and drug resistance in multiple myeloma. Blood 111: 3714–3772.

    Article  CAS  PubMed  Google Scholar 

  • Cobbold LC, Spriggs KA, Haines SJ, Dobbyn HC, Hayes C, de Moor CH et al. (2008). Identification of internal ribosome entry segment (IRES)-trans-acting factors for the Myc family of IRESs. Mol Cell Biol 28: 40–49.

    Article  CAS  PubMed  Google Scholar 

  • Dalton WS, Durie BGM, Alberts DS, Gerlach JH, Cress AE . (1986). Characterisation of a new drug-resistant human myeloma cell line that expresses P-glycoprotein. Cancer Res 46: 5125–5130.

    CAS  PubMed  Google Scholar 

  • Drach J, Kaufmann H, Urbauer E, Schreiber S, Ackermann J, Huber H . (2000). The biology of multiple myeloma. J Cancer Res Clin Oncol 126: 441–447.

    Article  CAS  PubMed  Google Scholar 

  • Evans JR, Mitchell SA, Spriggs KA, Ostrowski J, Bomsztyk K, Ostarek D et al. (2003). Members of the poly (rC) binding protein family stimulate the activity of the c-myc internal ribosome entry segment in vitro and in vivo. Oncogene 22: 6068–6076.

    Article  CAS  Google Scholar 

  • Evdokimova V, Tognon C, Ng T, Ruzanov P, Melnyk N, Fink D et al. (2009). Translational activation of snail1 and other developmentally regulated transcription factors by YB-1 promotes an epithelial–mesenchymal transition. Cancer Cell 15: 402–415.

    Article  CAS  PubMed  Google Scholar 

  • He X, Pool M, Darcy KM, Lim SB, Auersperg N, Coon JS et al. (2007). Knockdown of polypyrimidine tract-binding protein suppresses ovarian tumor cell growth and invasiveness in vitro. Oncogene 26: 4961–4968.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Herold S, Herkert B, Eilers M . (2009). Facilitating replication under stress: an oncogenic function of MYC? Nat Rev Cancer 9: 441–444.

    Article  CAS  PubMed  Google Scholar 

  • Ho PJ, Campbell LJ, Gibson J, Brown R, Joshua D . (2002). The biology and cytogenetics of multiple myeloma. Rev Clin Exp Hematol 6: 276–300.

    Article  CAS  PubMed  Google Scholar 

  • Jo OD, Martin J, Bernath A, Masri J, Lichtenstein A, Gera J . (2008). Heterogeneous nuclear ribonucleoprotein A1 regulates cyclin D1 and c-myc internal ribosome entry site function through Akt signaling. J Biol Chem 283: 23274–23287.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Johannes G, Sarnow P . (1998). Cap-independent polysomal association of natural mRNAs encoding c-myc, Bip, and eIF4G conferred by internal ribosome entry sites. RNA 4: 1500–1513.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kuehl WM, Bergsagel PL . (2002). Multiple myeloma: evolving genetic events and host interactions. Nat Rev Cancer 2: 175–187.

    Article  CAS  PubMed  Google Scholar 

  • Le Quesne JPC, Stoneley M, Fraser GA, Willis AE . (2001). Derivation of a structural Model for the c-myc IRES. J Mol Biol 310: 111–126.

    Article  CAS  PubMed  Google Scholar 

  • Meyer N, Penn LZ . (2008). Myc-timeline reflecting on 25 years with MYC. Nat Rev Cancer 8: 976–990.

    Article  CAS  PubMed  Google Scholar 

  • Mitchell SA, Spriggs KA, Bushell M, Evans JR, Stoneley M, Le Quesne JPC et al. (2005). Identification of a motif that mediates polypyrimidine tract-binding protein-dependent internal ribosome entry. Genes Dev 19: 1556–1571.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mitchell SA, Spriggs KA, Coldwell MJ, Jackson RJ, Willis AE . (2003). The Apaf-1 internal ribosome entry segment attains the correct structural conformation for function via interactions with PTB and unr. Mol Cell 11: 757–711.

    Article  CAS  PubMed  Google Scholar 

  • Nanbru C, Lafon I, Audiger S, Gensac G, Vagner S, Huez G et al. (1997). Alternative translation of the proto-oncogene c-myc by an internal ribosome entry site. J Biol Chem 272: 32061–32066.

    Article  CAS  PubMed  Google Scholar 

  • Paulin FEM, Chappell SA, Willis AE . (1998). A single nucleotide change in the c-myc internal ribosome entry segment leads to enhanced binding of a group of protein factors. Nucleic Acids Res 26: 3097–3103.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Paulin FEM, West MJ, Sullivan NF, Whitney RL, Lyne L, Willis AE . (1996). Aberrant translational control of the c-myc gene in multiple myeloma. Oncogene 13: 505–513.

    CAS  PubMed  Google Scholar 

  • Shi YJ, Frost PJ, Hoang BQ, Benavides A, Sharma S, Gera JF et al. (2008). IL-6-induced stimulation of c-myc translation in multiple myeloma cells is mediated by myc internal ribosome entry site function and the RNA-binding protein, hnRNP A1. Cancer Res 68: 10215–10222.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sonenberg N, Hinnebusch AG . (2009). Regulation of translation initiation in eukaryotes: mechanisms and biological targets. Cell 136: 731–745.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Spriggs KA, Cobbold LC, Jopling CL, Cooper RE, Wilson LA, Stoneley M et al. (2009). Canonical initiation factor requirements of the myc family of internal ribosome entry segments. Mol Cell Biol 29: 1565–1574.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Stoneley M, Chappell S, Jopling C, Dickens M, MacFarlane M, Willis A . (2000). c-Myc protein synthesis is initiated from the internal ribosome entry segment during apoptosis. Mol Cell Biol 20: 1162–1169.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Stoneley M, Paulin FEM, Le Quesne JPC, Chappell SA, Willis AE . (1998). C-Myc 5′ untranslated region contains an internal ribosome entry segment. Oncogene 16: 423–428.

    Article  CAS  PubMed  Google Scholar 

  • Stoneley M, Willis AE . (2004a). Cellular internal ribosome entry segments: structures, trans-acting factors and regulation of gene expression. Oncogene 23: 3200–3207.

    Article  CAS  PubMed  Google Scholar 

  • Stoneley M, Willis AE . (2004b). Cellular internal ribosome entry segments; structures, trans-acting factors and regulation of gene expression. Oncogene 23: 3200–3207.

    Article  CAS  PubMed  Google Scholar 

  • Subkhankulova T, Mitchell SA, Willis AE . (2001). Internal ribosome entry segment mediated initiation of c-Myc protein synthesis following genotoxic stress. Biochem J 359: 183–192.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sutherland BW, Kucab J, Wu J, Lee C, Cheang MCU, Yorida E et al. (2005). Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells. Oncogene 24: 4281–4292.

    Article  CAS  PubMed  Google Scholar 

  • Vafa O, Wade M, Kern S, Beeche M, Pandita TK, Hampton GM et al. (2002). c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability. Mol Cell 9: 1031–1044.

    Article  CAS  PubMed  Google Scholar 

  • Wang C, Norton JT, Ghosh S, Kim J, Fushimi K, Wu JY et al. (2008). Polypyrimidine tract-binding protein (PTB) differentially affects malignancy in a cell line-dependent manner. J Biol Chem 283: 20277–20287.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This work was funded by grants from the BBSRC (LCC, HAK) and CRUK (LAW, AVK). Martin Bushell is a BBSRC David Philips fellow and Anne Willis holds a BBSRC professorial fellowship. We thank Professor Dalton (Moffitt Cancer Center, Florida, USA) for providing the cell line 8226/R5.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A E Willis.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on the Oncogene website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cobbold, L., Wilson, L., Sawicka, K. et al. Upregulated c-myc expression in multiple myeloma by internal ribosome entry results from increased interactions with and expression of PTB-1 and YB-1. Oncogene 29, 2884–2891 (2010). https://doi.org/10.1038/onc.2010.31

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/onc.2010.31

Keywords

This article is cited by

Search

Quick links